Finance

Lists
Why is SBFM down 9.02%?
Dive Deeper
SBFM:NASDAQ
Sunshine Biopharma Inc
$0.22
-9.02%
(-0.022) 1D
$0.23
+4.09% (+0.0090)
Pre-market
Closed: Oct 20, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SBFM...
Open
$0.23
High
$0.24
Low
$0.21
Mkt. cap
3.37M
Avg. vol.
10.86M
Volume
5.26K
52-wk high
$23.20
52-wk low
$0.19
EPS
-$10.03
Beta
1.35
Shares outstanding
4.31M
No. of employees
50
Open
$0.23
High
$0.24
Low
$0.21
Mkt. cap
3.37M
Avg. vol.
10.86M
Volume
5.26K
52-wk high
$23.20
52-wk low
$0.19
EPS
-$10.03
Beta
1.35
Shares outstanding
4.31M
No. of employees
50
News stories
From web sources and news partners
About Sunshine Biopharma Inc
CEO-
Employees50
Founded2006
HeadquartersFort Lauderdale, Florida, United States
SectorBiotechnology
Websitesunshinebiopharma.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
9.42M
8.58M
8.09M
9.26M
Cost of goods sold
6.34M
5.55M
5.91M
6.84M
Cost of revenue
6.34M
5.55M
5.91M
6.84M
Research and development expenses
119.30K
73.50K
31.72K
13.22K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.27M
4.39M
3.34M
3.81M
Operating expense
3.61M
4.69M
3.58M
4.04M
Total operating expenses
9.95M
10.24M
9.48M
10.88M
Operating income
-531.96K
-1.66M
-1.40M
-1.61M
Other non operating income
-
-
103.32K
-
EBT including unusual items
-1.02M
-1.73M
-1.24M
-1.56M
EBT excluding unusual items
-456.36K
-1.60M
-1.24M
-1.56M
Income tax expense
-137.44K
408.37K
-
-
Effective tax rate
13.46%
-23.57%
-
-
Other operating expenses
119.91K
126.54K
129.66K
138.49K
Net income
-883.82K
-2.14M
-1.24M
-1.56M
Net profit margin
-9.39%
-24.96%
-15.38%
-16.88%
Earnings per share
-
-
-
-
Interest and investment income
75.35K
57.47K
48.43K
48.82K
Interest expense
-
-
-
-
Net interest expenses
75.35K
57.47K
48.43K
48.82K
Depreciation and amortization charges
95.82K
98.92K
76.86K
77.97K
EBITDA
-435.80K
-1.56M
-1.32M
-1.53M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps